BioRestorative Therapies, Inc. (BRTX) stock
BRTXNasdaqServices-Misc Health & Allied Services, NECFiscal year ends December 31
$1.34−0.08 (-5.63%)
Close on Nov 17, 2026Market cap $34.14MP/E –Yield –
BioRestorative Therapies operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
BioRestorative Therapies's operating cash flow for the twelve months ending Mar 31, 2026 was -$11.82M. For fiscal 2025 it was -$10.79M. The highest annual figure on record is -$729.22K in fiscal 2010.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$10.79M | – |
| FY2024 | Dec 31, 2024 | -$8.23M | – |
| FY2023 | Dec 31, 2023 | -$6.43M | – |
| FY2022 | Dec 31, 2022 | -$5.91M | – |
| FY2021 | Dec 31, 2021 | -$3.33M | – |
| FY2020 | Dec 31, 2020 | -$1.96M | – |
| FY2019 | Dec 31, 2019 | -$6.92M | – |
| FY2018 | Dec 31, 2018 | -$5.10M | – |
| FY2017 | Dec 31, 2017 | -$3.85M | – |
| FY2016 | Dec 31, 2016 | -$5.00M | – |
| FY2015 | Dec 31, 2015 | -$3.12M | – |
| FY2014 | Dec 31, 2014 | -$3.23M | – |
| FY2013 | Dec 31, 2013 | -$2.67M | – |
| FY2012 | Dec 31, 2012 | -$3.18M | – |
| FY2011 | Dec 31, 2011 | -$2.81M | – |
| FY2010 | Dec 31, 2010 | -$729.22K | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2026 | Mar 31, 2026 | -$3.81M | – |
| Q4 FY2025 | Dec 31, 2025 | -$2.42M | – |
| Q3 FY2025 | Sep 30, 2025 | -$2.90M | – |
| Q2 FY2025 | Jun 30, 2025 | -$2.69M | – |
| Q1 FY2025 | Mar 31, 2025 | -$2.78M | – |
| Q4 FY2024 | Dec 31, 2024 | -$2.35M | – |
| Q3 FY2024 | Sep 30, 2024 | -$1.70M | – |
| Q2 FY2024 | Jun 30, 2024 | -$1.87M | – |
| Q1 FY2024 | Mar 31, 2024 | -$2.32M | – |
| Q4 FY2023 | Dec 31, 2023 | -$1.59M | – |
| Q3 FY2023 | Sep 30, 2023 | -$1.18M | – |
| Q2 FY2023 | Jun 30, 2023 | -$1.28M | – |
| Q1 FY2023 | Mar 31, 2023 | -$2.38M | – |
| Q4 FY2022 | Dec 31, 2022 | -$1.62M | – |
| Q3 FY2022 | Sep 30, 2022 | -$1.45M | – |
| Q2 FY2022 | Jun 30, 2022 | -$1.25M | – |
| Q1 FY2022 | Mar 31, 2022 | -$1.59M | – |
| Q4 FY2021 | Dec 31, 2021 | -$1.15M | – |
| Q3 FY2021 | Sep 30, 2021 | -$629.36K | – |
| Q2 FY2021 | Jun 30, 2021 | -$741.83K | – |
| Q1 FY2021 | Mar 31, 2021 | -$813.70K | – |
| Q4 FY2020 | Dec 31, 2020 | -$572.12K | – |
| Q3 FY2020 | Sep 30, 2020 | -$523.06K | – |
| Q2 FY2020 | Jun 30, 2020 | -$420.44K | – |
| Q1 FY2020 | Mar 31, 2020 | -$448.65K | – |
| Q4 FY2019 | Dec 31, 2019 | -$1.81M | – |
| Q3 FY2019 | Sep 30, 2019 | -$1.71M | – |
| Q2 FY2019 | Jun 30, 2019 | -$1.42M | – |
| Q1 FY2019 | Mar 31, 2019 | -$1.98M | – |
| Q4 FY2018 | Dec 31, 2018 | -$1.55M | – |
| Q3 FY2018 | Sep 30, 2018 | -$1.35M | – |
| Q2 FY2018 | Jun 30, 2018 | -$1.04M | – |
| Q1 FY2018 | Mar 31, 2018 | -$1.16M | – |
| Q4 FY2017 | Dec 31, 2017 | -$1.36M | – |
| Q3 FY2017 | Sep 30, 2017 | -$509.16K | – |
| Q2 FY2017 | Jun 30, 2017 | -$765.96K | – |
| Q1 FY2017 | Mar 31, 2017 | -$1.22M | – |
| Q4 FY2016 | Dec 31, 2016 | -$1.06M | – |
| Q3 FY2016 | Sep 30, 2016 | -$1.21M | – |
| Q2 FY2016 | Jun 30, 2016 | -$1.02M | – |
See a number that looks wrong?